"Imbert Cancer Center offers more than just exceptional cancer care. We provide the personalized treatment you need for the best possible outcome. Opened in 2016, our center is designed to meet the needs of cancer patients and their families right here on the South Shore of Long Island. Offering comprehensive cancer care, along with imaging services, we provide a comfortable, peaceful and private environment that is conducive to healing in every way."

During the past decade, Northwell Health Imbert Cancer Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health Imbert Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "M.D. Anderson Cancer Center" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health Imbert Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health Imbert Cancer Center" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "HER2/Neu Negative" (2 trials) and "Invasive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Northwell Health Imbert Cancer Center" in a lesser frequency.

Most popular intervention types in "Northwell Health Imbert Cancer Center" are "Drug" (19 trials), "Other" (18 trials), "Procedure" (8 trials), "Biological" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (10 trials), "Questionnaire Administration" (8 trials), "Laboratory Biomarker Analysis" (7 trials), "Biospecimen Collection" (5 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health Imbert Cancer Center" are 20 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwell Health Imbert Cancer Center". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Northwell Health Imbert Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health Imbert Cancer Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".